CSF1R and cancer: Blockade of CSF1R has been shown to improve chemotherapy‐induced antitumor immunity in mouse cancer models leading to the hypothesis that targeting the CSF1R/CSF1 interaction in combination with immune checkpoint blockade could have a synergistic response.51, 52